The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices, program announcements, and requests for applications:

General Notices

• Notice of NIAAA Data-Sharing Policy for Human Subjects Grants Research Funded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) [2nd Revision]
  National Institute on Alcohol Abuse and Alcoholism
• Notice of Webinar for RFA-AG-20-020 "Nathan Shock Centers of Excellence in Basic Biology of Aging (P30 Clinical Trial Not Allowed)"
  National Institute on Aging
• Revised NIAID Policy for T32 and T35 Competing Renewal Application Submissions
  National Institute of Allergy and Infectious Diseases
• Pre-Application Webinars for Participant Engagement and Cancer Genome Sequencing (PE-CGS): Funding Opportunities (RFA-CA-19-045, RFA-CA-19-046)
  National Cancer Institute
• NOTICE OF INFORMATION: NIGMS Priorities for Sepsis Research
  National Institute of General Medical Sciences
• Notice of Clarification for NOT-MH-19-033, "Notice of Data Sharing Policy for the National Institute of Mental Health"
  National Institute of Mental Health
• Solicitation of Nominations for the 2020 National Institute of Neurological Disorders and Stroke (NINDS) Landis Award for Outstanding Mentorship
  National Institute of Neurological Disorders and Stroke
• Fast Healthcare Interoperability Resources (FHIR) Standard
  National Institutes of Health
• NIH Offers Assistance to Phase II HHS SBIR and STTR Awardees through the NIH Commercialization Accelerator Program (CAP) 2019-2020
  National Institutes of Health
• The NIH Office of Disease Prevention (ODP) Announces that the Workshop Panels Draft Report from the Pathways to Prevention Workshop: Achieving Health Equity in Preventive Services Is Now Available for Public Comment
  Office of Disease Prevention
• Updates for PAR-16-098 "Cooperative Research Agreements Related to World Trade Center Health Program (U01)"
  National Institute for Occupational Safety and Health
• Request for Information (RFI): Precision Nutrition Tools for Continuous Monitoring of Nutrients and Metabolites in Humans
  National Institute of Diabetes and Digestive and Kidney Diseases
• Request for Information (RFI): Regarding Bioinformatics/Computational Needs for NIDDK Investigators Engaged in Diabetes, Endocrinology and Metabolic Diseases Research
  National Institute of Diabetes and Digestive and Kidney Diseases
• Request for Information: Input into the National Institute of Neurological Disorders and Stroke Strategic Planning Process
  National Institute of Neurological Disorders and Stroke

Notice of Changes to Funding Opportunities

• Notice of Change to PAR-18-582 "Emotional Function in Normal Aging and/or MCI and AD/ADRD (R21 Clinical Trial Not Allowed)"
• Notice of Change to PAR-18-581 "Emotional Function in Normal Aging and/or MCI and AD/ADRD (R01 Clinical Trial Optional)"
  National Institute on Aging

• Notice to Extend the Expiration Date for PAR-18-296 "Complex Integrated Multi-Component Projects in Aging Research (U19 Clinical Trial Optional)"
  National Institute on Aging

• Notice of Change to RFA-AG-20-022 "Aging, Driving and Early Detection of Dementia (R01 Clinical Trial Optional)"
  National Institute on Aging

• Notice of Change to PAS-19-316 "Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional)"
• Notice of Change to PAS-19-317 "Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional)"
  National Institute on Aging

• Notice of NCI's participation on PAR-19-326, Reducing Stigma to Improve HIV/AIDS Prevention, Treatment, and Care in Low and Middle-Income Countries (R21 Clinical Trial Optional)
  National Cancer Institute

• Notice of NIDCR's Participation in PAR-18-831 "The Role of Epitranscriptomics in Development and Disease (R21 - Clinical Trial Not Allowed)"
• Notice of NIDCR's Participation in PAR-18-830 "The Role of Epitranscriptomics in Development and Disease (R01 - Clinical Trial Not Allowed)"
  National Institute of Dental and Craniofacial Research

• Notice to Terminate RFA-ES-18-009 "Maintain and Enrich Resource Infrastructure for Existing Environmental Epidemiology Cohorts (R24 Clinical Trial Not Allowed)"
  National Institute of Environmental Health Sciences

• Notice of Clarification of Program Director/Principal Investigator Eligibility for PAR-19-219 Maximizing Access to Research Careers (T34)
  National Institute of General Medical Sciences

• Notice of Change to the Cooperative Agreement in RFA-MH-19-149, BRAIN Initiative Cell Census Network (BICCN) Specialized Collaboratory on Human and Non-Human Primate Brain Cell Atlases (U01 Clinical Trial Not Allowed)
  National Institute of Mental Health
  National Institute of Neurological Disorders and Stroke

• Notice of Correction to RFA-RM-19-008 NIH Directors Early Independence Awards (DP5 Clinical Trial Optional)
  Office of Strategic Coordination (Common Fund)

Notices of Special Interest

• Notice of Special Interest: Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Applications Directed at the Adoption of the Fast Healthcare Interoperability Resources (FHIR) Standard
  National Institutes of Health
  National Center for Advancing Translational Sciences
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Eye Institute
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development 
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Institute of General Medical Sciences
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities 
  National Institute of Neurological Disorders and Stroke
  National Institute of Nursing Research
  National Library of Medicine

Funding Opportunities

• NIDDK Central Repositories Non-renewable Sample Access (X01 Clinical Trial Not Allowed)
  National Institute of Diabetes and Digestive and Kidney Diseases
  
  
   
• Palliative Care in Home and Community Settings (R21 Clinical Trial Optional)
• Palliative Care in Home and Community Settings (R01 Clinical Trial Optional)
  National Institute of Nursing Research
  
  
   
• Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional)
  National Cancer Institute
  
  
   
• Reducing Stigma to Improve HIV/AIDS Prevention, Treatment and Care in Low- and Middle-Income Countries (R21 Clinical Trial Optional)
  John E. Fogarty International Center
  National Cancer Institute
  National Institute on Drug Abuse
  National Institute of Mental Health
  
  
   
• Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional)
  National Institute on Drug Abuse
  
  
   
• Building Resources for the Basic Biology of Aging in Health Disparities Research (R24 Clinical Trial Not Allowed)
  National Institute on Aging
  
  
   
• Participant Engagement and Cancer Genome Sequencing (PE-CGS): Research Centers (U2C Clinical Trial Optional)
• Participant Engagement and Cancer Genome Sequencing (PE-CGS): Coordinating Center (U24 Clinical Trial Not Allowed)
  National Cancer Institute
    
  
   
• Revision Applications to Support the Application of Informatics Technology for Cancer Research (U01 Clinical Trials Optional)
• Revision Applications to Support the Application of Informatics Technology for Cancer Research (R01 Clinical Trials Optional)
• Revision Applications to Support the Application of Informatics Technology for Cancer Research (U24 Clinical Trials Optional)
  National Cancer Institute
  
  
   
• Catalyst Award In Diabetes, Endocrinology and Metabolic Diseases (DP1 Clinical Trial Not Allowed)
  National Institute of Diabetes and Digestive and Kidney Diseases
  
  
   
• Mechanism for Time-Sensitive Research Opportunities in Environmental Health Sciences (R21 Clinical Trial Not Allowed)
  National Institute of Environmental Health Sciences. 
  
   
• US Children with Perinatal HIV who were Born Internationally (R01 Clinical Trial Optional)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development 
  
  
   
• The Role of Stem/Progenitor Cells in the Pathogenesis and Treatment of Gynecologic Disorders (R21 Clinical Trial Optional)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development 

Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at dsp@uiowa.edu or 335-2123, or email Lynn Hudachek at lynn-hudachek @uiowa.edu